| Standard dosage | 10–50 mg/kg/d divided into two doses. |
| Contraindications | DCA induces dose-dependent and exposure-dependent reversible peripheral neuropathy. Patients with certain mitochondrial disorders (eg, MELAS) are probably more prone than others to the toxic effects of DCA. |
| Main drug interactions | None known. |
| Main side effects | DCA may induce mild elevation of liver transaminase. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.